Accuray reported $88.74M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Accuray ARAY:US $ 88.74M 9.1M
Atricure ATRC:US $ 54.56M 26.42M
Cardiovascular Systems CSII:US $ 66.42M 0.53M
Cryolife CRY:US $ 40.38M 11.03M
Edwards Lifesciences EW:US $ 1198.1M 167.2M
Hologic HOLX:US $ 2375.3M 84.5M
Inogen INGN:US $ 223.62M 10.22M
Mesa Laboratories MLAB:US $ 43.75M 5.6M
Natus Medical BABY:US $ 84.28M 8.69M
Orthofix International OFIX:US $ 59.54M 12.38M
Surmodics SRDX:US $ 20.07M 4.64M
Tandem Diabetes Care TNDM:US $ 114.97M 21.28M
Trinity Biotech TRIB:US $ 10.01M 15.9M